Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Antineoplastons induce responses in anaplastic astrocytoma patients

Dec. 15, 2008

RAP-011 prevents skeletal metastases in a mouse model of metastatic breast cancer

Dec. 12, 2008

Antileukemic effects of DCC-2036, DCC-2157 assessed in vivo

Dec. 12, 2008

New data on JAK2 inhibitors from Exelixis presented at ASH meeting

Dec. 12, 2008

Pivotal studies to follow phase IIb trial of AP-12009 in glioma

Dec. 12, 2008

Viralytics to test Cavatak in head and neck cancer

Dec. 12, 2008

Studies with AVL-101 highlight Bruton's tyrosine kinase as a target in B-cell lymphoma

Dec. 11, 2008

FDA approves Quintessence's IND to initiate phase I trial of QBI-139 in solid tumors

Dec. 11, 2008

Kiadis Pharma receives two FDA orphan drug designations for Reviroc

Dec. 11, 2008

Ozarelix's effects on histamine release assessed, administration routes compared

Dec. 11, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...